AGP Picks
View all

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on September 11, 2026

China Top 10 Sports Cap Solution Supplier: Showcasing Versatile Customization at ISPO
Vanguard Announces Cash Distributions for the Vanguard ETFs
HIP-HOP ICON ERIC B BREAKS NEW GROUND WITH ELECTRONIC SINGLE "I JUST CAME BY TO PARTY"
PLANET FITNESS DEADLINE SEPTEMBER 14th: Bragar Eagel & Squire, P.C. Reminds Planet Fitness, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before September 14th
HITN presents Townhall Los niños y el tiempo en pantalla: A Practical Guide for Hispanic Families on Healthy Screen Time in Early Childhood
Alaska Airlines Expands Nonstop Service Between Los Angeles and La Paz, Baja California Sur
The Elwood Celebrates Grand Opening in Downtown Kokomo — Free Food, Drinks, and Tours on September 15
Gelagen Gummies Introduces Gelagen Multi-Ingredient Dietary Supplement for Skin Wellness
Vystar Enters the Digital Economy Through R3alm Ownership
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
Office Desk Fountain Market Forecast To Hit $1.89Billion By 2030 Amid Strong Industry Growth
Dental Implant Surgery and Implant Restoration: What Patients Need to Know
PLNT SHAREHOLDER NOTICE Faruqi & Faruqi, LLP Reminds Planet Fitness Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
Tempest Therapeutics Announces Up to $7.5 Million Private Placement

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.